LDK 150MG NVR Pill - blue & white capsule/oblong
Generic Name: ceritinib
Pill with imprint LDK 150MG NVR is Blue & White, Capsule/Oblong and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Zykadia is used in the treatment of Non Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LDK 150MG NVR
Zykadia
- Generic Name
- ceritinib
- Imprint
- LDK 150MG NVR
- Strength
- 150 mg
- Color
- Blue & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0640 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hydroxypropyl cellulose,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
gelatin,
titanium dioxide,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about Zykadia (ceritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.